1. Home
  2. DLR vs BSX Comparison

DLR vs BSX Comparison

Compare DLR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Realty Trust Inc.

DLR

Digital Realty Trust Inc.

HOLD

Current Price

$200.27

Market Cap

71.7B

Sector

Real Estate

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$51.83

Market Cap

65.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLR
BSX
Founded
2004
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7B
65.8B
IPO Year
2004
2010

Fundamental Metrics

Financial Performance
Metric
DLR
BSX
Price
$200.27
$51.83
Analyst Decision
Buy
Strong Buy
Analyst Count
22
22
Target Price
$207.95
$93.18
AVG Volume (30 Days)
2.7M
18.3M
Earning Date
04-23-2026
04-22-2026
Dividend Yield
2.51%
N/A
EPS Growth
122.36
55.20
EPS
0.46
1.51
Revenue
$6,112,692,000.00
$9,076,000,000.00
Revenue This Year
$11.07
$11.85
Revenue Next Year
$10.54
$10.16
P/E Ratio
$429.57
$34.25
Revenue Growth
10.04
12.49
52 Week Low
$146.23
$42.20
52 Week High
$208.14
$109.50

Technical Indicators

Market Signals
Indicator
DLR
BSX
Relative Strength Index (RSI) 63.28 72.86
Support Level $172.54 $42.32
Resistance Level $207.81 $58.35
Average True Range (ATR) 4.80 1.66
MACD 0.83 0.62
Stochastic Oscillator 92.96 91.05

Price Performance

Historical Comparison
DLR
BSX

About DLR Digital Realty Trust Inc.

Digital Realty is one of the leading providers of cloud- and carrier-neutral data centers, offering colocation and interconnection services to hyperscalers and large businesses. Digital Realty operates 300 properties in 57 metropolitan areas across 31 countries, serving 5,000 customers. Renting physical space accounts for about 90% of Digital Realty's revenue. The firm enables hyperscalers and other clients to store servers, data, and networking equipment. The other 10% of revenue is generated primarily through interconnection services (8%) and other fee income (2%).

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: